Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidine

Journal of Physiology Paris

Volumn 95, Issue 1-6, 2001, Pages 315-324

  Prkacin, Ingrid ^a   Separovic, Jadranka ^a   Aralicia, Gorana ^a   Perovic, Darko ^a   Gjurasin, Miroslav ^a   Lovric Bencic, Martina ^a   Stancic Rokotov, Dinko ^a   Staresinic, Mario ^a   Anic, Tomislav ^a   Mikus, Darko ^a   Sikiric, Predrag ^a,b   Seiwerth, Sven ^a   Mise, Stjepan ^a   Rotkvic, Ivo ^a   Jagic, Vjekoslav ^a   Rucman, Rudolf ^a   Petek, Marijan ^a   Turkovic, Branko ^a   Marovic, Anton ^a   Sebecic, Bozidar ^a   Boban Blagaic, Alenka ^a   Kokic, Neven ^a   more..

^a UNIVERSITY OF ZAGREB   (Croatia)

^b Medical Faculty University of Zagreb Salata 11 PO Box 936 ^*  (Croatia)

Author keywords

Chronically alcohol drinking rats; Liver lesion; Pentadecapeptide BPC 157 (PL 10, PLD 116); Portal hypertension; Prevention; Propranolol; Ranitidine ineffective; Reversal

Indexed keywords

ALCOHOL; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALAN YLGLYCYLLEUCYLVALINE; PROPRANOLOL; RANITIDINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL NUCLEUS; CONFERENCE PAPER; CONTROLLED STUDY; DIGESTIVE SYSTEM INJURY; LIVER CELL; LIVER INJURY; LIVER WEIGHT; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD PRESSURE; PROPHYLAXIS; RAT; STEATOSIS;

ALCOHOL DRINKING; ANIMALS; ANTIHYPERTENSIVE AGENTS; HYPERTENSION, PORTAL; LIVER DISEASES, ALCOHOLIC; MALE; PEPTIDE FRAGMENTS; PROPRANOLOL; PROTEINS; RANITIDINE; RATS; RATS, WISTAR;

EID: 0034750927     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4257(01)00044-4     Document Type: Conference Paper

References (50)

1. Alcoholic hepatomegaly; accumulation of protein in the liver
2. Protective effects of newly isolated gastric peptide following hypoxic and reoxygenation injury in the isolated guinea pig heart
3. Involvement of nitric oxide and prostaglandins in gastric mucosal hyperaemia of portal hypertensive anaesthetized rats
4. The effect of alcohol induced hepatomegaly on portal hypertension in cirrhotic rats
5. Effects of propranolol and sucralfate on ethanol-induced gastric mucosal damage in chronic portal hypertensive rats
6. The influence of BPC 157 on nitric-oxyde agonists and antagonist induced lesions in broiler chicks
7. Alcohol induced hepatomegaly: Pathogenesis and role in the production of portal hypertension
8. A novel pentadecapeptide BPC 157 blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine
9. Dose dependent protective effect of BPC 157 in capasaicin induced rhinitis in rats
10. Effects of BPC 157 on the healing of corneal lesions
11. Influence of ethanol and microsomal drugs on hepatic hemodynamics
12. Cardiac plasma membrane physical properties and beta-adrenergic receptor function are unaltered in portal-hypertensive rats
13. Increased sinusoidal wall permeability and liver fatty change after two-thirds hepatectomy: An ultrastructural study in the rat
14. Pharmacology of portal-systemic collaterals in portal hypertensive rats: Role of endothelium
15. Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice
16. Beta-Receptor Blocking treatment in portal hypertension
17. Correlation of intrahepatic pressure with collagen in the Disse space and hepatomegaly in humans and in the rat
18. Hepatocyte enlargement and portal hypertension
19. The effect of new gastric juice peptide BPC on classic stress triad in stress procedure
20. Drug Interactions of H2-receptor antagonists involving cytochrome P450 (CYPs) enzymes: From the laboratory to the clinic
21. Cytoprotection by prostaglandins
22. Cysteamine-induced duodenal ulcers: A new model to test anti-ulcer agents
23. Mild irritants prevent gastric necrosis through "adaptive cytoprotection" mediated by prostaglandins
24. The protective effect of newly isolated peptide PL-10 in the iodoacetamide colitis in rats
25. The protective effect of a recently isolated gastric peptide in acute and chronic gastroduodenal injury
26. Propranolol reduces ethanol-induced gastric mucosal damage in portal hypertensive rats
27. Portal hypertension and gastric mucosal injury in rats
28. Increased susceptibility of the portal hypertensive gastric mucosa to damage
29. Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: A comparison with bone marrow and autologous cortical bone implantation
30. BPC 157 effect on healing
31. Effect of a novel pentadecapeptide BPC 157 and methylprednisolone in a murine model of inflammatory bowel disease
32. The effect of pentadecapeptide BPC 157 on inflammatory, non-inflammatory, direct and indirect pain and capsaicin neurotoxicity
33. The effect of pentadecapeptide BPC 157, H2 blockers and sucralfate on new vessels and new granulation tissue formation
34. Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress
35. Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine and atropine effect in cysteamine lesions in totally gastrectomized rats. A model study for cytoprotective studies
36. A new gastric juice peptide BPC - An overview of stomach/stress/organoprotection hypothesis and BPC beneficial effects
37. The influence of dopamine agonists and antagonists on indomethacin lesions in stomach and small intestine in rats
38. New model of cytoprotection/adaptive cytoprotection in rats: Endogenous small irritants, antiulcer agents and indomethacin
39. The beneficial effect of BPC 157, a 15 aminoacid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides
40. Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin, and capsaicin neurotoxicity
41. Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats
42. The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure
43. Hepatoprotective effect of BPC 157, a 15-amino acid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CC14 administration. A comparative study with dopamine agonists and somatostatin
44. Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in rats
45. Microvascular abnormalities of the portal hypertensive gastric mucosa
46. Ethanol induced damage to mucosal capillaries of rat stomach
47. An evaluation of the respective roles of portosystemic shunting and portal hypertension in rats upon the production of gonadal dysfunction in cirrhosis
48. Digestion of h-EGF, h-TGF alpha, and BPC-15 in human gastric juice
49. Effects of beta-adrenoreceptor antagonists on portal vein hypertension and ethanol-induced gastric mucosal damage in rats